DeviceTalks - Latest News and Information
The episode centers on Stephen, the newly appointed CEO of Vicarius Surgical, who argues that the company should be viewed primarily as a medical‑device firm rather than a pure robotics play. He outlines a “tested strategies” framework that prioritizes regulatory pathways, modular product design, and a scalable manufacturing footprint. Stephen details how recent capital raises will fund next‑generation robotic instruments and a suite of connectivity features that align with emerging smart‑hospital platforms. He also highlights the strategic addition of industry heavyweight Fred Mole to the board, signaling credibility and opening doors to partnership opportunities across the surgical ecosystem. A memorable quote from Stephen underscores the shift: “We are a medical‑device company first; robotics is the delivery mechanism.” The discussion also references broader market movements, including Pedal Surgical’s $25 million round and Abbott’s $20 billion diagnostic expansion, illustrating the competitive pressure to integrate devices, data, and hospital workflows. For investors and healthcare providers, Vicarius’s repositioning suggests a faster route to market clearance and reimbursement, while its focus on interoperable, smart‑hospital solutions could accelerate adoption in cost‑constrained health systems.
Dexcom CTO Girish Naganathan highlights that behavior change remains the toughest hurdle in diabetes care. By pairing continuous glucose monitoring (CGM) with generative AI, raw glucose data can be transformed into real‑time, actionable recommendations. The technology aims to shift guidance...
The episode centers on Armor Medical’s breakthrough wearable, which earned the company the grand prize at the MedTech Innovator competition. Host Tom Salmi interviews CEO Kelsey Mayo, highlighting how the sensor could alert patients and clinicians to impending severe health...
The video spotlights neurotechnology as a burgeoning alternative to pharmaceuticals for brain‑disorder treatment, emphasizing its capacity to directly modulate neural activity without crossing the blood‑brain barrier. Speakers highlight that synchronized light and sound—so‑called sensory ramps—can activate brain circuits, while brain‑computer interfaces,...
The video discusses the first prospective trial of pulsed‑field ablation (PFA) applied to ventricular tachycardia (VT), a technique previously limited to atrial procedures. Published in Circulation: Arrhythmia and Electrophysiology, the study marks a milestone in expanding PFA to the ventricle. Results...
The video spotlights why integrated technology is essential for outpatient surgery, drawing on the speaker’s experience as a physician, investor, and policy‑tech analyst. He observes a fragmented landscape where rising costs and misaligned incentives between volume and value hinder patient...
